A detailed history of Aquila Investment Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Aquila Investment Management LLC holds 28,000 shares of DXCM stock, worth $2.04 Million. This represents 3.28% of its overall portfolio holdings.

Number of Shares
28,000
Previous 28,000 -0.0%
Holding current value
$2.04 Million
Previous $3.88 Million 18.26%
% of portfolio
3.28%
Previous 3.51%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$75.49 - $124.16 $2.11 Million - $3.48 Million
28,000 New
28,000 $3.47 Million
Q2 2023

Jul 24, 2023

BUY
$112.47 - $130.98 $562,350 - $654,900
5,000 New
5,000 $642,000
Q4 2022

Jan 30, 2023

BUY
$84.98 - $122.67 $339,920 - $490,680
4,000 Added 28.57%
18,000 $2.04 Million
Q2 2022

Jul 19, 2022

BUY
$67.99 - $132.89 $883,869 - $1.73 Million
13,000 Added 1300.0%
14,000 $1.04 Million
Q1 2022

May 04, 2022

BUY
$94.08 - $130.2 $94,080 - $130,199
1,000 New
1,000 $512,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Aquila Investment Management LLC Portfolio

Follow Aquila Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquila Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquila Investment Management LLC with notifications on news.